FDA Drug Approvals for Cancer in 2016

Slideshow

This slide show highlights 2016 FDA approvals of cancer treatments, which to date include therapies for RCC, neuroendocrine tumors, Hodgkin lymphoma, CLL, sarcoma, bladder cancer, lung cancer, and breast cancer.

Recent Videos
3 experts are featured in this series.
3 experts are featured in this series.
3 experts in this video
3 experts in this video
3 experts in this video
Artificial intelligence may have the potential to enrich pathology practices to help identify aspects of tumor biology not seen with the human eye.
Related Content